BR9807408A - Polìmeros de vinila reticulados tendo ação de absorvente do ácido biliar - Google Patents

Polìmeros de vinila reticulados tendo ação de absorvente do ácido biliar

Info

Publication number
BR9807408A
BR9807408A BR9807408-3A BR9807408A BR9807408A BR 9807408 A BR9807408 A BR 9807408A BR 9807408 A BR9807408 A BR 9807408A BR 9807408 A BR9807408 A BR 9807408A
Authority
BR
Brazil
Prior art keywords
vinyl polymers
independently represent
cross
bile acid
alkyl
Prior art date
Application number
BR9807408-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Heinke Von Seggern
Axel Hoffmann
Eugen Falk
Brigitte Hoersch
Adolf Heinz Linkies
Heiner Glombik
Original Assignee
Aventis Res & Tech Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Res & Tech Gmbh & Co filed Critical Aventis Res & Tech Gmbh & Co
Publication of BR9807408A publication Critical patent/BR9807408A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F271/00Macromolecular compounds obtained by polymerising monomers on to polymers of nitrogen-containing monomers as defined in group C08F26/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/34Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • C08F20/36Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F22/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F22/10Esters
    • C08F22/1006Esters of polyhydric alcohols or polyhydric phenols, e.g. ethylene glycol dimethacrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F22/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F22/36Amides or imides
    • C08F22/38Amides
    • C08F22/385Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9807408-3A 1997-02-17 1998-02-17 Polìmeros de vinila reticulados tendo ação de absorvente do ácido biliar BR9807408A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19705963A DE19705963A1 (de) 1997-02-17 1997-02-17 Vernetzte Vinylpolymere mit Gallensäure-Adsorberwirkung
PCT/EP1998/000898 WO1998036002A1 (de) 1997-02-17 1998-02-17 Vernetzte vinylpolymere mit gallensäure-adsorberwirkung

Publications (1)

Publication Number Publication Date
BR9807408A true BR9807408A (pt) 2000-03-14

Family

ID=7820445

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807408-3A BR9807408A (pt) 1997-02-17 1998-02-17 Polìmeros de vinila reticulados tendo ação de absorvente do ácido biliar

Country Status (14)

Country Link
EP (1) EP0960141A1 (cs)
JP (1) JP2002515930A (cs)
KR (1) KR20000071167A (cs)
CN (1) CN1251112A (cs)
AU (1) AU728985B2 (cs)
BR (1) BR9807408A (cs)
CA (1) CA2281602A1 (cs)
CZ (1) CZ293299A3 (cs)
DE (1) DE19705963A1 (cs)
HU (1) HUP0001012A3 (cs)
PL (1) PL335106A1 (cs)
RU (1) RU99119911A (cs)
TR (1) TR199901978T2 (cs)
WO (1) WO1998036002A1 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4369499A (en) * 1998-06-30 2000-01-17 Aventis Research & Technologies Gmbh & Co. Kg Novel method for producing cross-linked vinyl polymers based on quaternary ammonium groups exhibiting a bile acid adsorbent effect
US6958212B1 (en) 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
DK1181323T3 (da) 1999-02-01 2011-10-17 Eidgenoess Tech Hochschule Biomaterialer dannet med nukleofil additionsreaktion med konjugerede uimættede grupper
US7291673B2 (en) 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US8282912B2 (en) 2002-03-22 2012-10-09 Kuros Biosurgery, AG Compositions for tissue augmentation
JP2005054145A (ja) * 2003-08-07 2005-03-03 Mitsubishi Gas Chem Co Inc ガスバリア性(メタ)アクリレート樹脂硬化物および塗料、接着剤、フィルム
WO2008125655A1 (en) 2007-04-13 2008-10-23 Kuros Biosurgery Ag Polymeric tissue sealant
JP6126498B2 (ja) * 2013-02-15 2017-05-10 富士フイルム株式会社 高分子機能性膜及びその製造方法
JP6071957B2 (ja) * 2014-03-07 2017-02-01 富士フイルム株式会社 イオン交換性ポリマーおよびその製造方法、電解質膜およびその製造方法ならびにイオン交換性ポリマー製造用組成物
WO2017038328A1 (ja) * 2015-08-31 2017-03-09 富士フイルム株式会社 イオン交換ポリマー、硬化性組成物、硬化物、部材、及び、装置
WO2019054797A1 (ko) 2017-09-15 2019-03-21 주식회사 엘지화학 중합성 조성물, 고분자 캡슐 및 이를 포함하는 섬유 유연제 조성물
CN110317588A (zh) * 2018-03-29 2019-10-11 中国石油化工股份有限公司 一种阳离子表面活性剂及其制备方法和起泡剂及其应用
IT201900020949A1 (it) * 2019-11-12 2021-05-12 Univ Degli Studi Di Trieste Monomero fotopolimerizzabile antibatterico

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206115A1 (es) * 1973-06-11 1976-06-30 Merck & Co Inc Procedimiento para preparar un polimero lineal no ramificado y no reticulado
GB9123683D0 (en) * 1991-11-07 1992-01-02 Sandoz Ltd Improvements in or relating to organic compounds
DE69307112T2 (de) * 1992-07-06 1997-04-17 Otsuka Kagaku Kk Polymerisierbares monomer, polymere und verfahren zu seiner herstellung
DE59307535D1 (de) * 1992-07-22 1997-11-20 Hoechst Ag Hydrophile Zentren aufweisende Polyvinylamin-Derivate, Verfahren zu ihrer Herstellung sowie die Verwendung der Verbindungen als Arzneimittel, Wirkstoffträger und Nahrungsmittelhilfsstoff
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor

Also Published As

Publication number Publication date
AU6498398A (en) 1998-09-08
PL335106A1 (en) 2000-04-10
CZ293299A3 (cs) 1999-12-15
AU728985B2 (en) 2001-01-25
EP0960141A1 (de) 1999-12-01
JP2002515930A (ja) 2002-05-28
CA2281602A1 (en) 1998-08-20
HUP0001012A3 (en) 2001-11-28
CN1251112A (zh) 2000-04-19
TR199901978T2 (xx) 2000-06-21
HUP0001012A2 (hu) 2000-09-28
RU99119911A (ru) 2001-06-27
KR20000071167A (ko) 2000-11-25
WO1998036002A1 (de) 1998-08-20
DE19705963A1 (de) 1998-08-20

Similar Documents

Publication Publication Date Title
BR9807408A (pt) Polìmeros de vinila reticulados tendo ação de absorvente do ácido biliar
BR9815778A (pt) Composição nanocompósita de polìmero
NO2016007I1 (no) Susoktokog
MX166955B (es) Composicion absorbente de luz ultravioleta
EA200100588A1 (ru) Пиперидины как модуляторы ccr5
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
BR9813842A (pt) Papel fino macio tendo uma composição amaciante que contém um eletrólito depositada sobre o mesmo
DK96588A (da) Antitumirmiddel indeholdende makromolekylaere platinforbindelser
DE69435155D1 (de) Zusuammensetzungen zur Behandlung von Krebs mittels Viren
BR9904372A (pt) Sulfanil-silanos
DE69725825D1 (de) 5-HT1F-Agonisten
BR9806752A (pt) Ftalazinonas.
DE69811062D1 (de) Polyaromatische antivirale zusammensetzungen
BR9811948A (pt) Secretores de hormÈnio do crescimento
ES2133324T3 (es) Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso.
BRPI0518198A (pt) métodos de interrupção melhorados para processos de inativação de células hemácias
BR9909229A (pt) Composição condicionadora de cabelo aquosa
BR9916680A (pt) Derivados da 3,3-biarilpiperidina e2,2-biarilmorfolina
BR9610527A (pt) Novos derivados de substâncias de ciclodepsipeptìdeo pf1022
BR0110208A (pt) Composições e terapias para distúrbios associados com hiperlipidemia
KR870000913A (ko) 치과용 접착 조성물
ATA21197A (de) Verwendung von thermoplastischen elastomeren zur verbesserung der stabilität von polyolefinen gegenüber ionisierender strahlung
EA200100141A1 (ru) Терапевтическая композиция на основе изофлавоноидов для применения в лечении опухолей цитотоксическими агентами
GT199800081A (es) Inhibidores de la farnesil transferasa combinados con inhibidores de la hmg coa reductasa para el tratamiento delcancer.
BR9802544A (pt) Derivados de hexahidro-1,4-diazepina os seus sais.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]